JD.com’s healthcare spinoff has filed for an initial public offering after raising more than $1.9bn in equity funding from investors including Hillhouse Capital and Citic Capital.
JD Health, the medical product retailer spun off by China-based e-commerce group JD.com, has filed for an initial public offering on the Hong Kong Stock Exchange’s Main Board.
JD Health operates a pharmacy service, selling products such as prescription drugs, medical supplies, contact lenses and vitamins. It also provides telemedicine consultations for a range of conditions.
Hedge fund manager Hillhouse Capital contributed to a series B round in August 2020, with the filing showing the round to have…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
